| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | J Moodley | |
| P Gathiram | |||
| P2860 | cites work | Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3 | Q24304467 |
| Oxidative stress in preeclampsia and the role of free fetal hemoglobin | Q26830141 | ||
| A leading role for the immune system in the pathophysiology of preeclampsia | Q27003069 | ||
| Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond | Q27027039 | ||
| Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation | Q28200154 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener | Q28363080 | ||
| Vascular endothelial growth factor (VEGF) and its receptors | Q29615390 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Hydrogen sulfide is an endogenous stimulator of angiogenesis. | Q30492603 | ||
| Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia | Q30576991 | ||
| The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. | Q33755648 | ||
| Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array | Q33761815 | ||
| Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field | Q33901191 | ||
| Expression of cystathionine β-synthase and cystathionine γ-lyase in human pregnant myometrium and their roles in the control of uterine contractility | Q34008944 | ||
| Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy | Q34379583 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin | Q34599422 | ||
| Angiogenic factors and preeclampsia | Q34714082 | ||
| Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia | Q34777981 | ||
| Pre-eclampsia: pathophysiology, diagnosis, and management | Q35141777 | ||
| Trophoblast deportation and the maternal inflammatory response in pre-eclampsia | Q35190881 | ||
| Th1/Th2 balance in preeclampsia | Q35190885 | ||
| Subclassification of preeclampsia | Q35196220 | ||
| Pathogenesis of preeclampsia: the genetic component | Q35607465 | ||
| Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome | Q35750283 | ||
| Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights | Q35941009 | ||
| The "Great Obstetrical Syndromes" are associated with disorders of deep placentation | Q36015615 | ||
| Recent advances in understanding of preeclampsia. | Q36255904 | ||
| TGF-beta superfamily expression and actions in the endometrium and placenta. | Q36555340 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| Immunoregulation in normal pregnancy and pre-eclampsia: an overview | Q36684096 | ||
| Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia | Q36686796 | ||
| The role of the immune system in preeclampsia | Q36791219 | ||
| A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma | Q36984261 | ||
| The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia | Q37041658 | ||
| Placental origins of preeclampsia: challenging the current hypothesis | Q37079631 | ||
| A systematic review of endoglin gene expression in preeclampsia | Q37102951 | ||
| Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia | Q37107851 | ||
| Altered global gene expression in first trimester placentas of women destined to develop preeclampsia | Q37155561 | ||
| Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection | Q37362662 | ||
| Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer | Q37620853 | ||
| First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction | Q37694427 | ||
| Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state | Q37723245 | ||
| Uterine NK cells: active regulators at the maternal-fetal interface. | Q37726609 | ||
| The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis | Q38049205 | ||
| Redefining preeclampsia using placenta-derived biomarkers. | Q38086495 | ||
| Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. | Q38116097 | ||
| Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors | Q38152072 | ||
| Review: the ADAM metalloproteinases - novel regulators of trophoblast invasion? | Q38162651 | ||
| The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad. | Q38176651 | ||
| IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? | Q38183247 | ||
| Beyond pregnancy: modulation of trophoblast invasion and its consequences for fetal growth and long-term children's health | Q38219218 | ||
| Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia | Q38311843 | ||
| Preeclampsia: an excessive maternal inflammatory response to pregnancy | Q40824430 | ||
| Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity | Q41292409 | ||
| The renin-angiotensin-aldosterone system in pre-eclampsia | Q41554361 | ||
| Sildenafil citrate improves fetal outcomes in pregnant, L-NAME treated, Sprague-Dawley rats | Q43207984 | ||
| Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of survivin gene | Q43299185 | ||
| Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies | Q43991495 | ||
| High levels of heat shock protein 70 are associated with pro-inflammatory cytokines and may differentiate early- from late-onset preeclampsia | Q45123899 | ||
| IL-10, TNF-α & IFN-γ: potential early biomarkers for preeclampsia | Q45197229 | ||
| Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague-Dawley rats | Q46298778 | ||
| Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state | Q46320511 | ||
| MicroRNA-376c impairs transforming growth factor-β and nodal signaling to promote trophoblast cell proliferation and invasion | Q46320867 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction | Q46870238 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| High molecular weight angiotensinogen levels in hypertensive pregnant women | Q47265007 | ||
| Placental perfusion in normal pregnancy and early and late preeclampsia: a magnetic resonance imaging study. | Q50801716 | ||
| Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. | Q50963577 | ||
| Hydrogen sulfide producing enzymes in pregnancy and preeclampsia. | Q53181366 | ||
| Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. | Q54491741 | ||
| Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. | Q54570213 | ||
| Placental stress and pre-eclampsia: a revised view. | Q54774592 | ||
| Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. | Q54782424 | ||
| Response to Letter Regarding Article, “Dysregulation of Hydrogen Sulfide (H 2 S) Producing Enzyme Cystathionine γ-lyase (CSE) Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia” | Q57316857 | ||
| Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia | Q58778301 | ||
| The optimization of a chronic nitric oxide synthase (NOS) inhibition model of pre-eclampsia by evaluating physiological changes | Q61808454 | ||
| Early and Late Preeclampsia | Q61853974 | ||
| Nitric oxide-mediated vasodilation in human pregnancy | Q73281658 | ||
| Re: "Abortion,changed paternity, and risk of preeclampsia in nulliparous women" | Q79171603 | ||
| Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles | Q80178439 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pre-eclampsia | Q61335 |
| ischemia | Q188151 | ||
| pathogenesis | Q372016 | ||
| membrane protein | Q423042 | ||
| intrauterine growth restriction | Q1671598 | ||
| cell surface receptor | Q2476074 | ||
| maternal health | Q6786626 | ||
| enzyme | Q8047 | ||
| vascular endothelial growth factor receptor 1 (VEGFR1) | Q24778444 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 71-8 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Cardiovascular Journal of Africa | Q26830987 |
| P1476 | title | Pre-eclampsia: its pathogenesis and pathophysiolgy | |
| P478 | volume | 27 |
| Q92153167 | A data-driven model to study utero-ovarian blood flow physiology during pregnancy |
| Q88008760 | Alteration of heat shock protein 20 expression in preeclamptic patients and its effect in vascular and coagulation function |
| Q89800074 | Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation |
| Q92524380 | Association between RUNX3 gene polymorphisms in severe preeclampsia and its clinical features |
| Q64229512 | Association between polymorphisms in CXCR2 gene and preeclampsia |
| Q37631028 | Autonomic imbalance captures maternal and fetal circulatory response to pre-eclampsia |
| Q37297222 | Early Prognostic Factors for the Progress of Preeclampsia - Our Experience in the Period 2010-2011. |
| Q90465595 | Exploration of the regulation and control mechanisms of miR-145 in trophoblast cell proliferation and invasion |
| Q99630017 | Extra Virgin Olive Oil Modulates Vasodilator Enzyme Level by Repairing Angiogenesis Function in Rat Model of Preeclampsia |
| Q90150015 | Gastrodin improves preeclampsia-induced cell apoptosis by regulation of TLR4/NF-κB in rats |
| Q55331790 | Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating p38 MAPK Signaling Pathway. |
| Q90480280 | Long Non-coding RNA Gas5 Is Associated With Preeclampsia and Regulates Biological Behaviors of Trophoblast via MicroRNA-21 |
| Q36198793 | Maternal cardiac haemodynamics in severe pre-eclampsia complicated by acute pulmonary oedema: A review |
| Q48254919 | Mothers' experiences of having a premature infant due to pre-eclampsia. |
| Q55265408 | PD-1/PD-L1 regulates Treg differentiation in pregnancy-induced hypertension. |
| Q99237742 | Placental Microbial Colonization and Its Association With Pre-eclampsia |
| Q55689583 | Placental protein 13: An important biological protein in preeclampsia. |
| Q51129015 | Plasma biomarkers for the identification of women at risk for early-onset preeclampsia. |
| Q47841212 | Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal |
| Q97546356 | Recent insights on indirect mechanisms in developmental toxicity of nanomaterials |
| Q49984490 | Role of angiogenic factors in the pathogenesis and management of pre-eclampsia |
| Q33713592 | Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe |
| Q48232820 | Takayasu arteritis a cause of hypertensive disorder of pregnancy: a case report. |
| Q92827544 | The REVAMP study: research exploring various aspects and mechanisms in preeclampsia: study protocol |
| Q89542793 | The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia? |
| Q47955968 | The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia |
| Q92146814 | The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis |
| Q39039141 | Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review |
| Q64077840 | Use of antidepressants and anxiolytics in early pregnancy and the risk of preeclampsia and gestational hypertension: a prospective study |
| Q93108704 | sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective |
Search more.